Your browser doesn't support javascript.
loading
Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort.
Negoescu, Diana M; Enns, Eva A; Swanhorst, Brooke; Baumgartner, Bonnie; Campbell, James P; Osterman, Mark T; Papamichael, Konstantinos; Cheifetz, Adam S; Vaughn, Byron P.
Afiliação
  • Negoescu DM; Department of Industrial and Systems Engineering, University of Minnesota College of Science and Engineering, Minneapolis, MN.
  • Enns EA; Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN.
  • Swanhorst B; Department of Industrial and Systems Engineering, University of Minnesota College of Science and Engineering, Minneapolis, MN.
  • Baumgartner B; Department of Industrial and Systems Engineering, University of Minnesota College of Science and Engineering, Minneapolis, MN.
  • Campbell JP; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota Medical School, Minneapolis, MN.
  • Osterman MT; Division of Gastroenterology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
  • Papamichael K; Center for Inflammatory Bowel Disease, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Cheifetz AS; Center for Inflammatory Bowel Disease, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  • Vaughn BP; Division of Gastroenterology, Hepatology and Nutrition, University of Minnesota Medical School, Minneapolis, MN.
Inflamm Bowel Dis ; 26(1): 103-111, 2020 01 01.
Article em En | MEDLINE | ID: mdl-31184366

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Monitoramento de Medicamentos / Infliximab Tipo de estudo: Etiology_studies / Evaluation_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Inflamm Bowel Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Mongólia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doença de Crohn / Monitoramento de Medicamentos / Infliximab Tipo de estudo: Etiology_studies / Evaluation_studies / Health_economic_evaluation / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans Idioma: En Revista: Inflamm Bowel Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Mongólia País de publicação: Reino Unido